Mesenchymal To Epithelial Transition (met) - Cancer Science

Relevant Publications

Role of savolitinib in advanced gastric adenocarcinoma with meningeal carcinomatosis and cerebellar metastasis: A case report.

Issue Release: 2024

Unlocking cellular plasticity: Enhancing human iPSC reprogramming through bromodomain inhibition and extracellular matrix gene expression regulation.

Issue Release: 2024

PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer.

Issue Release: 2024

Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic V600EMT colon cancer patient with acquired amplification and fusion: a case report.

Issue Release: 2024

Electrospun EU/HPMC nanofibers decorated by ZIF-8 nanoparticle as the advanced electrochemical biosensor modifier for sensitive and selective detection of c-MET cancer biomarker in human plasma sample.

Issue Release: 2024

Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer.

Issue Release: 2024

Mesenchymal-epithelial transition and AXL inhibitor TP-0903 sensitise triple-negative breast cancer cells to the antimalarial compound, artesunate.

Issue Release: 2024

Identifying Qingkailing ingredients-dependent mesenchymal-epithelial transition factor-axiation \"π\" structuring module with angiogenesis and neurogenesis effects.

Issue Release: 2024

Single-cell morphodynamical trajectories enable prediction of gene expression accompanying cell state change.

Issue Release: 2024

Plasma ddPCR for the detection of amplification in advanced NSCLC patients: a comparative real-world study.

Issue Release: 2024

Aberrant trophoblastic differentiation in human cancer: An emerging novel therapeutic target (Review).

Issue Release: 2024

Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.

Issue Release: 2024

Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations.

Issue Release: 2024

Integrated transcriptome sequencing and weighted gene co-expression network analysis reveals key genes of papillary thyroid carcinomas.

Issue Release: 2024

LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion and contributes to rituximab resistance in diffuse large B-cell lymphoma.

Issue Release: 2024

Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome.

Issue Release: 2024

Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway.

Issue Release: 2024

Identification of lysyl oxidase as an adipocyte-secreted mediator that promotes a partial mesenchymal-to-epithelial transition in MDA-MB-231 cells.

Issue Release: 2024

Dux activates metabolism-lactylation-MET network during early iPSC reprogramming with Brg1 as the histone lactylation reader.

Issue Release: 2024

Single-cell transcriptomics reveals the intra-tumoral heterogeneity and SQSTM1/P62 and Wnt/β-catenin mediated epithelial to mesenchymal transition and stemness of triple-negative breast cancer.

Issue Release: 2024

What role do biomarkers play in cancer treatment?

How Do Blister Packs Benefit Cancer Patients?

How to Prepare for Bone Marrow Aspiration?

What are the Benefits of Telemedicine in Cancer Care?

Which Types of Cancer Are Most Commonly Associated with Dysphagia?

How do Keratins Affect Tumor Behavior?

Which Cancers are Associated with MSI-H?

What are the Challenges in Using Natural Compounds for Cancer Treatment?

How is Processed Meat Linked to Cancer?

Why is Tumor Location Important in Cancer?

Mesenchymal To Epithelial Transition (met) - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics